This study strictly followed the Declaration of Helsinki and was approved by the Ethics Committee of Shengli Oilfield Central Hospital. All subjects signed informed consent forms before participating ...
Matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) are involved in a variety of physiologic growth and development and pathophysiologic inflammatory conditions. We hypothesized that 1) ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have patented 5-[2,7-diazaspiro[3.5]nonan-7-yl]-5-[4-phenoxyphenyl]hexahydropyrimidine-2,4,6-trione derivatives acting as matrix ...
AnaSpec has announced the release of three new MMP recombinant proteins, MMP-1, MMP-9 and MMP-12. These proteins, derived from the catalytic domain of the proteins, are supplied as activated proteins ...
Gastrointestinal drug development firm EA Pharma negotiated an exclusive, global license to develop, manufacture, and market Calypso Biotech’s preclinical-stage fully human anti-MMP-9 (matrix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results